WMIS WMIC

World Molecular Imaging Society (WMIS) is an international organization dedicated to developing and promoting multimodal molecular imaging research worldwide.

[WMIS WMIC @WMISWMIC]

The window to submit your abstract for WMIC 2026 is closing fast. Submit your work and join us this September in Salt Lake City.

Abstract deadline: Friday, April 17, 2026

🔗 https://t.co/zC5uJH86S7

#WMIC2026 #MolecularImaging #SLC

[WMIS WMIC @WMISWMIC]

The countdown is in single digits! Your research belongs on the global stage. Spend a few hours today finishing that abstract. https://t.co/zC5uJH86S7

#WMIC2026 #molecularImaging #SLC

[WMIS WMIC @WMISWMIC]

ONE WEEK TO GO! This is your final Friday to finalize those abstracts. Join us in SLC for the premiere event in molecular imaging. Portal closes April 17. https://t.co/zC5uJH86S7

#WMIC2026 #SLC #molecularImaging

[WMIS WMIC @WMISWMIC]

Ready to click submit? Make sure your abstract meets all the formatting guidelines. Check the portal today to ensure a smooth submission process: https://t.co/zC5uJH86S7

#WMIC2026 #molecularImaging #SLC

[WMIS WMIC @WMISWMIC]

What have you been working on in the lab? From probe development to clinical applications, we want to see your data at WMIC 2026. Two weeks left! Deadline: April 17. https://t.co/zC5uJH86S7

#WMIC2026 #molecularImaging #SLC

[WMIS WMIC @WMISWMIC]

Three weeks. 21 days. The clock is ticking toward the April 17 deadline. Don’t wait until the final hour: get your abstract submission in early! https://t.co/zC5uJH86S7

#WMIC2026 #molecularImaging #SLC

[WMIS WMIC @WMISWMIC]

Hyperpolarized (129)Xe-MRI was used to evaluate the role of the MAPK pathway in wound healing in a murine model of emphysema.

Check out the full study by Kimura et al. here: https://t.co/A3rxT0HK4T

[WMIS WMIC @WMISWMIC]

Elevate your research! Presenting at WMIC 2026 is an opportunity for feedback from the brightest minds and networking that lasts a lifetime.

Start your submission today! https://t.co/zC5uJH86S7

#WMIC2026 #molecularImaging

[WMIS WMIC @WMISWMIC]

Pafolacianine (Cytalux®), an FDA-approved intraoperative imaging agent, was evaluated for the fluorescence-guided surgery of head and neck squamous cell carcinoma.

Read more on this preclinical investigation by Mani et al. here: https://t.co/qIVqOVONEs

[WMIS WMIC @WMISWMIC]

Physics, biology, chemistry, and medicine: WMIC is where imaging worlds collide. Whether you are a trainee or tenured, your research deserves a global audience.

⏰ 6 weeks until abstract deadline!
Submit here: https://t.co/zC5uJH86S7

#WMIC2026 #SLC #molecularImaging

[WMIS WMIC @WMISWMIC]

Gan et al. have performed a first-in-human clinical trial of (89)Zr-Bintrafusp Alfa, a bifunctional fusion protein, in non-small cell lung cancer patients with PD-L1-expressing tumors.

Check out the full article! https://t.co/dCQsbjStqO

[WMIS WMIC @WMISWMIC]

A molecular imaging showdown! In this study, Zheng et al. set out to compare the diagnostic performances of (68)Ga-FAPI-PET, (18)FDG-PET, enterography, and intestinal ultrasound in patients with Crohn’s disease.

Read more here! https://t.co/yXUoL6JqHw

[WMIS WMIC @WMISWMIC]

WMIC 2026 official hotel room block is now open!

WMIS has secured discounted rates at three walkable hotels near the Salt Palace Convention Center in Salt Lake City.

🔗 Hotel details + booking info: https://t.co/N5h2IZp9QG

#WMIC2026 #MolecularImaging #SaltLakeCity #WMIS

[WMIS WMIC @WMISWMIC]

#MIBArticleHighlight Peng et al. have developed a new approach to antiplatelet therapy via local infusion of ticagrelor-loaded PLGA magnetic microspheres (PFTm). Upon infusion of PFTm, local thrombosis was inhibited. Read more here! https://t.co/p1qkKGq1Nf

[WMIS WMIC @WMISWMIC]

#MIBArticleHighlight Park et al. report the simultaneous use of dopamine transporter and amyloid tracers in Parkinson’s disease and Alzheimer’s disease mouse models, demonstrating the potential of dual-target PET imaging. Access the full article here! https://t.co/iwwpxVwsVj

[WMIS WMIC @WMISWMIC]

#MIBArticleHighlight In the latest installment of #MIBGuides, Simo et al. describe step-by-step protocols for the production of trastuzumab with zirconium-89 and copper-64. Click here for the full Guide! https://t.co/0w0RRlfRfd

[WMIS WMIC @WMISWMIC]

#MIBArticleHighlight In this Phase 2 clinical trial follow-up, Warmerdam et al. demonstrated that patients whose surgical approach was less invasive and more effective based on NIRF showed favorable long-term outcomes. Check out the full article! https://t.co/hrkQs8AmDL

[WMIS WMIC @WMISWMIC]

As new therapies become more targeted, we need imaging tools that can guide decisions throughout the treatment journey.

Molecular imaging helps identify the right patients, monitor their response, and adapt care over time.

Share your research at WMIS https://t.co/Tx0oWJem26

[WMIS WMIC @WMISWMIC]

🌟 Upcoming WMIS Webinar 🌟
Join us on Sept 8 at 11 AM ET for a live discussion with Teri Odom, PhD: “Nanoparticle Shape Effects on Nano-Bio Interactions”

📅 Sept 8 | 11 AM ET
🔗 Register here: https://t.co/RvPI3pN8BL

#Nanomedicine #Nanoparticles #CancerResearch

[WMIS WMIC @WMISWMIC]

LAST DAY TO SUBMIT - TODAY, AUGUST 29, 2025
New Approach Methodologies (NAMs) in Preclinical Imaging Special Call for Posters

We are seeking forward-thinking poster contributions that demonstrate integration of NAMs in preclinical imaging

👉 Details: https://t.co/nZamIIMgJy